Spinal Cannabinoid Receptor Type 2 Agonist Reduces Mechanical Allodynia and Induces Mitogen-Activated Protein Kinase Phosphatases in a Rat Model of Neuropathic Pain
Abstract Peripheral nerve injury generally results in spinal neuronal and glial plastic changes associated with chronic behavioral hypersensitivity. Spinal mitogen-activated protein kinases (MAPKs), eg, p38 or extracellular signal-regulated kinases (ERKs), are instrumental in the development of chro...
Saved in:
Published in | The journal of pain Vol. 13; no. 9; pp. 836 - 848 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.09.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Peripheral nerve injury generally results in spinal neuronal and glial plastic changes associated with chronic behavioral hypersensitivity. Spinal mitogen-activated protein kinases (MAPKs), eg, p38 or extracellular signal-regulated kinases (ERKs), are instrumental in the development of chronic allodynia in rodents, and new p38 inhibitors have shown potential in acute and neuropathic pain patients. We have previously shown that the cannabinoid type 2 receptor agonist JWH015 inhibits ERK activity by inducing MAPK phosphatase (MKP)-1 and MKP-3 (the major regulators of MAPKs) in vitro in microglial cells. Therefore, we decided to investigate the role of these phosphatases in the mechanisms of action of JWH015 in vivo using the rat L5 nerve transection model of neuropathic pain. We observed that peripheral nerve injury reduced spinal MKP-1/3 expression and activity and that intrathecal JWH015 reduced established L5 nerve injury-induced allodynia, enhanced spinal MKP-1/3 expression and activity, and reduced the phosphorylated form of p38 and ERK-1/2. Triptolide, a pharmacological blocker of MKP-1 and MKP-3 expression, inhibited JWH015’s effects, suggesting that JWH015 exerts its antinociceptive effects by modulating MKP-1 and MKP-3. JWH015-induced antinociception and MKP-1 and MKP-3 expression were inhibited by the cannabinoid type 2 receptor antagonist AM630. Our data suggest that MKP-1 and MKP-3 are potential targets for novel analgesic drugs. Perspective MAPKs are pivotal in the development of chronic allodynia in rodent models of neuropathic pain. A cannabinoid type 2 receptor agonist, JWH015, reduced neuropathic allodynia in rats by reducing MAPK phosphorylation and inducing spinal MAPK phosphatases 1 and 3, the major regulators of MAPKs. |
---|---|
AbstractList | Peripheral nerve injury generally results in spinal neuronal and glial plastic changes associated with chronic behavioral hypersensitivity. Spinal mitogen-activated protein kinases (MAPKs), e.g., p38 or extracellular signal-regulated kinases (ERKs), are instrumental in the development of chronic allodynia in rodents, and new p38 inhibitors have shown potential in acute and neuropathic pain patients. We have previously shown that the cannabinoid type 2 receptor agonist JWH015 inhibits ERK activity by inducing MAPK phosphatase (MKP)-1 and MKP-3 (the major regulators of MAPKs) in vitro in microglial cells. Therefore, we decided to investigate the role of these phosphatases in the mechanisms of action of JWH015 in vivo using the rat L5 nerve transection model of neuropathic pain. We observed that peripheral nerve injury reduced spinal MKP-1/3 expression and activity and that intrathecal JWH015 reduced established L5 nerve-injury-induced allodynia, enhanced spinal MKP-1/3 expression and activity, and reduced the phosphorylated form of p38 and ERK-1/2. Triptolide, a pharmacological blocker of MKP-1 and MKP-3 expression, inhibited JWH015’s effects, suggesting that JWH015 exerts its antinociceptive effects by modulating MKP-1 and MKP-3. JWH015-induced antinociception and MKP-1 and MKP-3 expression were inhibited by the cannabinoid type 2 receptor antagonist AM630. Our data suggest that MKP-1 and MKP-3 are potential targets for novel analgesic drugs. Peripheral nerve injury generally results in spinal neuronal and glial plastic changes associated with chronic behavioral hypersensitivity. Spinal mitogen-activated protein kinases (MAPKs), eg, p38 or extracellular signal-regulated kinases (ERKs), are instrumental in the development of chronic allodynia in rodents, and new p38 inhibitors have shown potential in acute and neuropathic pain patients. We have previously shown that the cannabinoid type 2 receptor agonist JWH015 inhibits ERK activity by inducing MAPK phosphatase (MKP)-1 and MKP-3 (the major regulators of MAPKs) in vitro in microglial cells. Therefore, we decided to investigate the role of these phosphatases in the mechanisms of action of JWH015 in vivo using the rat L5 nerve transection model of neuropathic pain. We observed that peripheral nerve injury reduced spinal MKP-1/3 expression and activity and that intrathecal JWH015 reduced established L5 nerve injury-induced allodynia, enhanced spinal MKP-1/3 expression and activity, and reduced the phosphorylated form of p38 and ERK-1/2. Triptolide, a pharmacological blocker of MKP-1 and MKP-3 expression, inhibited JWH015's effects, suggesting that JWH015 exerts its antinociceptive effects by modulating MKP-1 and MKP-3. JWH015-induced antinociception and MKP-1 and MKP-3 expression were inhibited by the cannabinoid type 2 receptor antagonist AM630. Our data suggest that MKP-1 and MKP-3 are potential targets for novel analgesic drugs. MAPKs are pivotal in the development of chronic allodynia in rodent models of neuropathic pain. A cannabinoid type 2 receptor agonist, JWH015, reduced neuropathic allodynia in rats by reducing MAPK phosphorylation and inducing spinal MAPK phosphatases 1 and 3, the major regulators of MAPKs. Abstract Peripheral nerve injury generally results in spinal neuronal and glial plastic changes associated with chronic behavioral hypersensitivity. Spinal mitogen-activated protein kinases (MAPKs), eg, p38 or extracellular signal-regulated kinases (ERKs), are instrumental in the development of chronic allodynia in rodents, and new p38 inhibitors have shown potential in acute and neuropathic pain patients. We have previously shown that the cannabinoid type 2 receptor agonist JWH015 inhibits ERK activity by inducing MAPK phosphatase (MKP)-1 and MKP-3 (the major regulators of MAPKs) in vitro in microglial cells. Therefore, we decided to investigate the role of these phosphatases in the mechanisms of action of JWH015 in vivo using the rat L5 nerve transection model of neuropathic pain. We observed that peripheral nerve injury reduced spinal MKP-1/3 expression and activity and that intrathecal JWH015 reduced established L5 nerve injury-induced allodynia, enhanced spinal MKP-1/3 expression and activity, and reduced the phosphorylated form of p38 and ERK-1/2. Triptolide, a pharmacological blocker of MKP-1 and MKP-3 expression, inhibited JWH015’s effects, suggesting that JWH015 exerts its antinociceptive effects by modulating MKP-1 and MKP-3. JWH015-induced antinociception and MKP-1 and MKP-3 expression were inhibited by the cannabinoid type 2 receptor antagonist AM630. Our data suggest that MKP-1 and MKP-3 are potential targets for novel analgesic drugs. Perspective MAPKs are pivotal in the development of chronic allodynia in rodent models of neuropathic pain. A cannabinoid type 2 receptor agonist, JWH015, reduced neuropathic allodynia in rats by reducing MAPK phosphorylation and inducing spinal MAPK phosphatases 1 and 3, the major regulators of MAPKs. |
Author | Martinez, Elena Romero-Sandoval, E. Alfonso DeLeo, Joyce A Landry, Russell P |
AuthorAffiliation | a Dartmouth Medical School, Department of Anesthesiology, Lebanon, New Hampshire, USA b Department of Pharmacology/Toxicology, Dartmouth Medical School, Hanover, New Hampshire, USA |
AuthorAffiliation_xml | – name: a Dartmouth Medical School, Department of Anesthesiology, Lebanon, New Hampshire, USA – name: b Department of Pharmacology/Toxicology, Dartmouth Medical School, Hanover, New Hampshire, USA |
Author_xml | – sequence: 1 fullname: Landry, Russell P – sequence: 2 fullname: Martinez, Elena – sequence: 3 fullname: DeLeo, Joyce A – sequence: 4 fullname: Romero-Sandoval, E. Alfonso |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22901764$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUttuEzEQtVARbQNfgIT8A5v6sl5vHqgURYVWtBC15dly7NnEYWuvbCdS_ocPxUlKBbzgF49mzpmj0Tnn6MQHDwi9p2RMCW0u1uP1oJ0fM0LZmIgxofwVOqOCtVVb1_LkUDeVmBByis5TWhNCqZDyDTplbEKobOoz9PNhcF73eKa91wvng7P4HgwMOUT8uBsAMzxdBu9SLn27MZDwHZiV9s4U2rTvg915p7H2Ft_4Z4DLYQm-mprstjqDxfMYMjiPvxSxBHi-CmlY6VzqhEtb43ud8V2w0OPQ4a-wiWHQeeUMnpcT36LXne4TvHv-R-j7p6vH2XV1--3zzWx6WxnRklzV0rSdlXLRUqHrmrdd2-mGtVIsWj6p9cRAbTvLrCYN75jgnAnKTdNJITouF3yELo97h83iCawBn6Pu1RDdk447FbRTf0-8W6ll2CpexHh5I8SPC0wMKUXoXriUqL1paq0Opqm9aYoIVUwrrA9_yr5wfrtUAB-PACjHbx1ElYwDb8C6CCYrG9x_BC7_4ZveHQz8ATtI67CJJQNJUZUKRz3sc7OPDWWENI2Q_Bfa18Nw |
CitedBy_id | crossref_primary_10_1177_1744806916688220 crossref_primary_10_1016_j_neuroscience_2021_11_007 crossref_primary_10_1016_j_neulet_2014_05_039 crossref_primary_10_1097_j_pain_0000000000000329 crossref_primary_10_1007_s43440_021_00250_2 crossref_primary_10_1097_FBP_0000000000000337 crossref_primary_10_1213_ANE_0000000000000146 crossref_primary_10_1111_cns_14807 crossref_primary_10_3389_fnmol_2023_1142852 crossref_primary_10_3389_fphar_2021_781237 crossref_primary_10_3390_ijms24032348 crossref_primary_10_1016_j_neuint_2022_105296 crossref_primary_10_3390_biomedicines11061546 crossref_primary_10_1111_ejn_12440 crossref_primary_10_1016_j_mcn_2016_08_003 crossref_primary_10_1111_bph_13324 crossref_primary_10_1124_mol_115_098483 crossref_primary_10_3390_healthcare12131335 crossref_primary_10_3390_ijms18091963 crossref_primary_10_1080_01616412_2019_1642437 crossref_primary_10_1371_journal_pone_0148065 crossref_primary_10_3892_mmr_2017_7479 crossref_primary_10_1080_00207454_2019_1667785 crossref_primary_10_1136_rapm_2019_101262 crossref_primary_10_1016_j_biopsych_2014_04_009 crossref_primary_10_1186_s12974_018_1316_0 crossref_primary_10_1007_s11655_015_2045_1 crossref_primary_10_1177_1744806920904292 crossref_primary_10_3389_fnmol_2017_00448 crossref_primary_10_4236_pp_2018_912038 crossref_primary_10_1517_13543784_2014_918603 crossref_primary_10_1016_j_neulet_2015_04_002 crossref_primary_10_1016_j_phrs_2017_02_019 crossref_primary_10_1186_s12974_014_0191_6 crossref_primary_10_1016_j_brainresbull_2018_12_012 crossref_primary_10_3390_ijms20081999 crossref_primary_10_1111_1440_1681_12416 crossref_primary_10_1016_j_ejcb_2023_151324 crossref_primary_10_1080_01616412_2019_1672391 crossref_primary_10_1080_17512433_2016_1204231 crossref_primary_10_1213_ANE_0000000000001129 crossref_primary_10_1523_JNEUROSCI_5605_12_2013 crossref_primary_10_1038_s41598_019_43858_4 crossref_primary_10_3390_ijms22010019 |
Cites_doi | 10.1097/ALN.0b013e318167af74 10.1186/1744-8069-6-16 10.1177/147323000903700227 10.1016/j.neuron.2005.11.027 10.1111/j.1471-4159.2008.05550.x 10.1016/0165-0270(94)90144-9 10.1523/JNEUROSCI.2396-04.2004 10.1016/j.bbrc.2009.03.061 10.4103/1658-354X.87267 10.1523/JNEUROSCI.23-10-04017.2003 10.1371/journal.pone.0010891 10.1016/j.ijom.2011.12.014 10.1016/j.ejpain.2011.04.005 10.1038/nm1723 10.1016/j.biomaterials.2011.10.031 10.1213/ane.0b013e31818c7cbd 10.1371/journal.pone.0013754 10.1111/j.1471-4159.2007.04535.x 10.1016/j.cellsig.2011.12.013 10.1186/1744-8069-8-34 10.1038/sj.bjp.0706699 10.1111/j.1471-4159.2008.05653.x 10.1038/ncb989 10.1084/jem.20060336 10.1111/j.1365-2125.2011.04137.x 10.1097/ALN.0b013e318190bc16 10.1038/nrd2289 10.1124/jpet.107.119941 10.1016/j.molimm.2011.06.439 10.1177/0091270011405496 10.1016/j.jaci.2010.06.007 10.1186/1744-8069-5-25 10.1016/j.brainresrev.2008.12.011 10.1021/bi035346b 10.4049/jimmunol.1003957 10.1089/107632702753725003 10.1074/jbc.M411760200 |
ContentType | Journal Article |
Copyright | American Pain Society 2012 American Pain Society Copyright © 2012 American Pain Society. Published by Elsevier Inc. All rights reserved. 2012 The American Pain Society. Published by Elsevier Inc. All rights reserved. 2012 |
Copyright_xml | – notice: American Pain Society – notice: 2012 American Pain Society – notice: Copyright © 2012 American Pain Society. Published by Elsevier Inc. All rights reserved. – notice: 2012 The American Pain Society. Published by Elsevier Inc. All rights reserved. 2012 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1016/j.jpain.2012.05.013 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1528-8447 |
EndPage | 848 |
ExternalDocumentID | 10_1016_j_jpain_2012_05_013 22901764 S1526590012006657 1_s2_0_S1526590012006657 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: Hitchcock Foundation award 2011-2012 – fundername: American Pain Society 2008 Future Leaders in Pain Research – fundername: Rita Allen Foundation & American Pain Society 2011 Pain – fundername: National Institute of Drug Abuse grantid: DA025211; DA11276 – fundername: NIDA NIH HHS grantid: DA025211 – fundername: NIDA NIH HHS grantid: DA11276 – fundername: NIDA NIH HHS grantid: R01 DA025211 – fundername: NIDA NIH HHS grantid: R01 DA011276 |
GroupedDBID | - 0R 1 123 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5VS 7-5 71M 8P AABNK AACTN AAEDT AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAWTL AAXLA AAXUO ABBQC ABCQJ ABIVO ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFO ACGFS ACJTP ADBBV ADEZE AEKER AENEX AEVXI AFTJW AFXBA AGHFR AGUBO AGWIK AGYEJ AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AZFZN BLXMC CAG COF CS3 DU5 EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU G- G-Q GBLVA HVGLF HZ IHE IPNFZ J1W J5H K K-O L7B LCYCR M M41 MO0 MOBAO N9A NAHTW O-L O9- OAUVE OG. OS- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SEL SES SEW SSZ T5K UHS UNMZH UV1 --- --K --M .~1 0R~ 8P~ AAEDW ABJNI ADMUD EFLBG HZ~ ~G- 0SF AAHBH ADVLN AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-c580t-47c8fd77b815a4438f8fa62875b8394a9ce4dfd2da063f25332513c6f755f37b3 |
IEDL.DBID | .~1 |
ISSN | 1526-5900 |
IngestDate | Tue Sep 17 21:21:13 EDT 2024 Thu Sep 26 20:01:36 EDT 2024 Sat Sep 28 08:03:43 EDT 2024 Fri Feb 23 02:26:49 EST 2024 Thu Aug 18 17:15:12 EDT 2022 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | mitogen-activated protein kinase (MAPK) CB2 receptors MAPK phosphatase pain spinal cord |
Language | English |
License | Copyright © 2012 American Pain Society. Published by Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c580t-47c8fd77b815a4438f8fa62875b8394a9ce4dfd2da063f25332513c6f755f37b3 |
Notes | These authors contributed equally to this study. (current affiliation) Department of Biology, Emmanuel College, Boston, Massachusetts, USA. |
OpenAccessLink | http://www.jpain.org/article/S1526590012006657/pdf |
PMID | 22901764 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3438333 crossref_primary_10_1016_j_jpain_2012_05_013 pubmed_primary_22901764 elsevier_sciencedirect_doi_10_1016_j_jpain_2012_05_013 elsevier_clinicalkeyesjournals_1_s2_0_S1526590012006657 |
PublicationCentury | 2000 |
PublicationDate | 2012-09-01 |
PublicationDateYYYYMMDD | 2012-09-01 |
PublicationDate_xml | – month: 09 year: 2012 text: 2012-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The journal of pain |
PublicationTitleAlternate | J Pain |
PublicationYear | 2012 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Alkaitis MS, Ndong C, Landry RP, DeLeo JA, A. R-SE: Reduced Antinociceptive Effect of Repeated Treatment with a Cannabinoid Receptor Type 2 Agonist in Cannabinoid-Tolerant Rats Following Spinal Nerve Transection. In Jeffrey, Camps, Rommel, Mackay (bib14) 2007; 6 Chaplan, Bach, Pogrel, Chung, Yaksh (bib7) 1994; 53 Korhonen, Turpeinen, Taimi, Nieminen, Goulas, Moilanen (bib25) 2011; 48 Srivastava, Sudan, Saha (bib34) 2011; 186 Toth, Jedrzejewski, Ellis, Frey (bib36) 2010; 6 Kizjakina, Bryson, Grandinetti, Reineke (bib23) 2012; 33 Shipp, Lee, Yu, Pufall, Zhang, Scott, Wang (bib33) 2010; 5 Gozdz, Vashishta, Kalita, Szatmari, Zheng, Tamiya, Delamere, Hetman (bib10) 2008; 106 Jin, Hu, Peterson, Eng, Levin, Wells, Beckman, Kumar, Seibold, Karungi, Zoratti, Gaggin, Campbell, Galanter, Chapela, Rodriguez-Santana, Watson, Meade, Lenoir, Rodriguez-Cintron, Avila, Lanfear, Burchard, Williams (bib17) 2010; 126 Ndong, Landry, Deleo, Romero-Sandoval (bib28) 2012; 8 Hamm, Krott, Breibach, Blindt, Bosserhoff (bib12) 2002; 8 Abraham, Lawrence, Kleiman, Warden, Medghalchi, Tuckermann, Saklatvala, Clark (bib1) 2006; 203 Alkaitis, Solorzano, Landry, Piomelli, DeLeo, Romero-Sandoval (bib3) 2010; 5 Eljaschewitsch, Witting, Mawrin, Lee, Schmidt, Wolf, Hoertnagl, Raine, Schneider-Stock, Nitsch, Ullrich (bib8) 2006; 49 Gong, Xue, Jiao, Jing, Wang (bib9) 2008; 107 Tong, Daniels, Black, Chang, Protter, Desjardins (bib35) 2012; 52 Kim, Rice, Denu (bib22) 2003; 42 Romero-Sandoval, Horvath, Landry, DeLeo (bib31) 2009; 5 Kawasaki, Xu, Wang, Park, Zhuang, Tan, Gao, Roy, Corfas, Lo, Ji (bib21) 2008; 14 Chang, Luo, Palmer, Sutton, Wilson, Barbier, Breitenbucher, Chaplan, Webb (bib6) 2006; 148 Zhou, Ling, Dheen (bib39) 2007; 102 Hagg, Alserius, Noori, Ruusalepp, Ivert, Tegner, Bjorkegren, Skogsberg (bib11) 2011; 27 Ji, Gereau, Malcangio, Strichartz (bib15) 2009; 60 Russo, Loverme, La Rana, Compton, Parrott, Duranti, Tontini, Mor, Tarzia, Calignano, Piomelli (bib32) 2007; 322 Karbarz, Luo, Chang, Tham, Palmer, Wilson, Wennerholm, Brown, Scott, Apodaca, Keith, Wu, Breitenbucher, Chaplan, Webb (bib18) 2009; 108 Li, Winter, Arends, Jay, Le, Young, Huggins (bib26) 2012; 73 Bani-Hashem, Hassan-Nasab, Pour, Maleh, Nabavi, Jabbari (bib5) 2011; 5 Kawakami, Rodriguez-Leon, Koth, Buscher, Itoh, Raya, Ng, Esteban, Takahashi, Henrique, Schwarz, Asahara, Izpisua Belmonte (bib19) 2003; 5 Kawasaki, Kohno, Zhuang, Brenner, Wang, Van Der Meer, Befort, Woolf, Ji (bib20) 2004; 24 Klongnoi, Kaewpradub, Boonsiriseth, Wongsirichat (bib24) 2012; 41 Zhao, Shepherd, Manson, Nelin, Sorokin, Liu (bib38) 2005; 280 Anand, Shenoy, Palmer, Baines, Lai, Robertson, Bird, Ostenfeld, Chizh (bib4) 2011; 15 Manetsch, Che, Seidel, Chen, Ammit (bib27) 2012; 24 Wen, Suter, Ji, Yeh, Wu, Wang, Kohno, Sun, Wang (bib37) 2009; 110 Jin, Zhuang, Woolf, Ji (bib16) 2003; 23 Romero-Sandoval, Nutile-McMenemy, DeLeo (bib30) 2008; 108 (Racz, G.B. and Noe, C.E., Eds.), InTech, 2012, pp. 101-122. Available from Huang, Fan, Ji, Zhang, Bao, Zhang (bib13) 2009; 37 Oride, Kanasaki, Purwana, Miyazaki (bib29) 2009; 382 19289102 - Biochem Biophys Res Commun. 2009 May 15;382(4):663-7 15590669 - J Biol Chem. 2005 Mar 4;280(9):8101-8 21764456 - Mol Immunol. 2011 Sep;48(15-16):2059-68 15385614 - J Neurosci. 2004 Sep 22;24(38):8310-21 20673984 - J Allergy Clin Immunol. 2010 Sep;126(3):618-25.e1-2 22044402 - Br J Clin Pharmacol. 2012 May;73(5):706-16 18665890 - J Neurochem. 2008 Sep;106(5):2056-67 19095868 - Anesth Analg. 2009 Jan;108(1):316-29 17412883 - J Pharmacol Exp Ther. 2007 Jul;322(1):236-42 21424112 - Int J Mol Med. 2011 Jun;27(6):851-7 22138032 - Biomaterials. 2012 Feb;33(6):1851-62 22540262 - Mol Pain. 2012;8:34 18264108 - Nat Med. 2008 Mar;14(3):331-6 22209181 - Int J Oral Maxillofac Surg. 2012 Mar;41(3):376-9 20236533 - Mol Pain. 2010;6:16 17473844 - Nat Rev Drug Discov. 2007 May;6(5):391-403 20531936 - PLoS One. 2010;5(5):e10891 19104183 - Anesthesiology. 2009 Jan;110(1):155-65 16501580 - Br J Pharmacol. 2006 May;148(1):102-13 14690430 - Biochemistry. 2003 Dec 30;42(51):15197-207 21060794 - PLoS One. 2010;5(10):e13754 21659629 - J Clin Pharmacol. 2012 May;52(5):717-28 21576029 - Eur J Pain. 2011 Nov;15(10):1040-8 19476641 - Mol Pain. 2009;5:25 22200679 - Cell Signal. 2012 Apr;24(4):907-13 17403137 - J Neurochem. 2007 Aug;102(3):667-78 18362605 - Anesthesiology. 2008 Apr;108(4):722-34 19383246 - J Int Med Res. 2009 Mar-Apr;37(2):511-9 22144925 - Saudi J Anaesth. 2011 Oct;5(4):382-6 21471446 - J Immunol. 2011 May 15;186(10):5863-72 18761708 - J Neurochem. 2008 Nov;107(3):779-88 12031113 - Tissue Eng. 2002 Apr;8(2):235-45 12764087 - J Neurosci. 2003 May 15;23(10):4017-22 16880258 - J Exp Med. 2006 Aug 7;203(8):1883-9 19150373 - Brain Res Rev. 2009 Apr;60(1):135-48 16387640 - Neuron. 2006 Jan 5;49(1):67-79 7990513 - J Neurosci Methods. 1994 Jul;53(1):55-63 12766772 - Nat Cell Biol. 2003 Jun;5(6):513-9 Manetsch (10.1016/j.jpain.2012.05.013_bib27) 2012; 24 Hamm (10.1016/j.jpain.2012.05.013_bib12) 2002; 8 Romero-Sandoval (10.1016/j.jpain.2012.05.013_bib30) 2008; 108 Li (10.1016/j.jpain.2012.05.013_bib26) 2012; 73 Klongnoi (10.1016/j.jpain.2012.05.013_bib24) 2012; 41 Wen (10.1016/j.jpain.2012.05.013_bib37) 2009; 110 Kawasaki (10.1016/j.jpain.2012.05.013_bib21) 2008; 14 Gozdz (10.1016/j.jpain.2012.05.013_bib10) 2008; 106 Kawasaki (10.1016/j.jpain.2012.05.013_bib20) 2004; 24 Tong (10.1016/j.jpain.2012.05.013_bib35) 2012; 52 Kizjakina (10.1016/j.jpain.2012.05.013_bib23) 2012; 33 Hagg (10.1016/j.jpain.2012.05.013_bib11) 2011; 27 Jeffrey (10.1016/j.jpain.2012.05.013_bib14) 2007; 6 Anand (10.1016/j.jpain.2012.05.013_bib4) 2011; 15 Ndong (10.1016/j.jpain.2012.05.013_bib28) 2012; 8 Chang (10.1016/j.jpain.2012.05.013_bib6) 2006; 148 Oride (10.1016/j.jpain.2012.05.013_bib29) 2009; 382 Gong (10.1016/j.jpain.2012.05.013_bib9) 2008; 107 Korhonen (10.1016/j.jpain.2012.05.013_bib25) 2011; 48 Alkaitis (10.1016/j.jpain.2012.05.013_bib3) 2010; 5 Zhou (10.1016/j.jpain.2012.05.013_bib39) 2007; 102 Romero-Sandoval (10.1016/j.jpain.2012.05.013_bib31) 2009; 5 Huang (10.1016/j.jpain.2012.05.013_bib13) 2009; 37 Chaplan (10.1016/j.jpain.2012.05.013_bib7) 1994; 53 Shipp (10.1016/j.jpain.2012.05.013_bib33) 2010; 5 Karbarz (10.1016/j.jpain.2012.05.013_bib18) 2009; 108 Bani-Hashem (10.1016/j.jpain.2012.05.013_bib5) 2011; 5 Srivastava (10.1016/j.jpain.2012.05.013_bib34) 2011; 186 Jin (10.1016/j.jpain.2012.05.013_bib16) 2003; 23 Zhao (10.1016/j.jpain.2012.05.013_bib38) 2005; 280 Jin (10.1016/j.jpain.2012.05.013_bib17) 2010; 126 Toth (10.1016/j.jpain.2012.05.013_bib36) 2010; 6 Russo (10.1016/j.jpain.2012.05.013_bib32) 2007; 322 Kawakami (10.1016/j.jpain.2012.05.013_bib19) 2003; 5 10.1016/j.jpain.2012.05.013_bib2 Kim (10.1016/j.jpain.2012.05.013_bib22) 2003; 42 Abraham (10.1016/j.jpain.2012.05.013_bib1) 2006; 203 Eljaschewitsch (10.1016/j.jpain.2012.05.013_bib8) 2006; 49 Ji (10.1016/j.jpain.2012.05.013_bib15) 2009; 60 |
References_xml | – volume: 382 start-page: 663 year: 2009 end-page: 667 ident: bib29 article-title: Possible involvement of mitogen-activated protein kinase phosphatase-1 (MKP-1) in thyrotropin-releasing hormone (TRH)-induced prolactin gene expression publication-title: Biochem Biophys Res Commun contributor: fullname: Miyazaki – volume: 27 start-page: 851 year: 2011 end-page: 857 ident: bib11 article-title: Blood levels of dual-specificity phosphatase-1 independently predict risk for post-operative morbidities causing prolonged hospitalization after coronary artery bypass grafting publication-title: Int J Mol Med contributor: fullname: Skogsberg – volume: 23 start-page: 4017 year: 2003 end-page: 4022 ident: bib16 article-title: p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain publication-title: J Neurosci contributor: fullname: Ji – volume: 49 start-page: 67 year: 2006 end-page: 79 ident: bib8 article-title: The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells publication-title: Neuron contributor: fullname: Ullrich – volume: 52 start-page: 717 year: 2012 end-page: 728 ident: bib35 article-title: Novel p38alpha Mitogen-activated protein kinase inhibitor shows analgesic efficacy in acute postsurgical dental pain publication-title: J Clin Pharmacol contributor: fullname: Desjardins – volume: 5 start-page: 382 year: 2011 end-page: 386 ident: bib5 article-title: Addition of intrathecal Dexamethasone to Bupivacaine for spinal anesthesia in orthopedic surgery publication-title: Saudi J Anaesth contributor: fullname: Jabbari – volume: 108 start-page: 316 year: 2009 end-page: 329 ident: bib18 article-title: Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase publication-title: Anesth Analg contributor: fullname: Webb – volume: 14 start-page: 331 year: 2008 end-page: 336 ident: bib21 article-title: Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain publication-title: Nat Med contributor: fullname: Ji – volume: 42 start-page: 15197 year: 2003 end-page: 15207 ident: bib22 article-title: Intramolecular dephosphorylation of ERK by MKP3 publication-title: Biochemistry contributor: fullname: Denu – volume: 48 start-page: 2059 year: 2011 end-page: 2068 ident: bib25 article-title: Attenuation of the acute inflammatory response by dual specificity phosphatase 1 by inhibition of p38 MAP kinase publication-title: Mol Immunol contributor: fullname: Moilanen – volume: 5 start-page: 25 year: 2009 ident: bib31 article-title: Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation publication-title: Mol Pain contributor: fullname: DeLeo – volume: 15 start-page: 1040 year: 2011 end-page: 1048 ident: bib4 article-title: Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury publication-title: Eur J Pain contributor: fullname: Chizh – volume: 102 start-page: 667 year: 2007 end-page: 678 ident: bib39 article-title: Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia publication-title: J Neurochem contributor: fullname: Dheen – volume: 203 start-page: 1883 year: 2006 end-page: 1889 ident: bib1 article-title: Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 publication-title: J Exp Med contributor: fullname: Clark – volume: 5 start-page: e10891 year: 2010 ident: bib3 article-title: Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain publication-title: PLoS One contributor: fullname: Romero-Sandoval – volume: 5 start-page: e13754 year: 2010 ident: bib33 article-title: Transcriptional regulation of human dual specificity protein phosphatase 1 (DUSP1) gene by glucocorticoids publication-title: PLoS One contributor: fullname: Wang – volume: 186 start-page: 5863 year: 2011 end-page: 5872 ident: bib34 article-title: CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection publication-title: J Immunol contributor: fullname: Saha – volume: 106 start-page: 2056 year: 2008 end-page: 2067 ident: bib10 article-title: Cisplatin-mediated activation of extracellular signal-regulated kinases 1/2 (ERK1/2) by inhibition of ERK1/2 phosphatases publication-title: J Neurochem contributor: fullname: Hetman – volume: 110 start-page: 155 year: 2009 end-page: 165 ident: bib37 article-title: Activation of p38 mitogen-activated protein kinase in spinal microglia contributes to incision-induced mechanical allodynia publication-title: Anesthesiology contributor: fullname: Wang – volume: 41 start-page: 376 year: 2012 end-page: 379 ident: bib24 article-title: Effect of single dose preoperative intramuscular dexamethasone injection on lower impacted third molar surgery publication-title: Int J Oral Maxillofac Surg contributor: fullname: Wongsirichat – volume: 8 start-page: 235 year: 2002 end-page: 245 ident: bib12 article-title: Efficient transfection method for primary cells publication-title: Tissue Eng contributor: fullname: Bosserhoff – volume: 280 start-page: 8101 year: 2005 end-page: 8108 ident: bib38 article-title: The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: Attenuation of proinflammatory cytokine biosynthesis via feedback control of p38 publication-title: J Biol Chem contributor: fullname: Liu – volume: 126 start-page: 618 year: 2010 end-page: 625 ident: bib17 article-title: Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients publication-title: J Allergy Clin Immunol contributor: fullname: Williams – volume: 5 start-page: 513 year: 2003 end-page: 519 ident: bib19 article-title: MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb publication-title: Nat Cell Biol contributor: fullname: Izpisua Belmonte – volume: 107 start-page: 779 year: 2008 end-page: 788 ident: bib9 article-title: Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and JNK in LPS-treated microglia publication-title: J Neurochem contributor: fullname: Wang – volume: 108 start-page: 722 year: 2008 end-page: 734 ident: bib30 article-title: Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury publication-title: Anesthesiology contributor: fullname: DeLeo – volume: 322 start-page: 236 year: 2007 end-page: 242 ident: bib32 article-title: The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice publication-title: J Pharmacol Exp Ther contributor: fullname: Piomelli – volume: 73 start-page: 706 year: 2012 end-page: 716 ident: bib26 article-title: Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects publication-title: Br J Clin Pharmacol contributor: fullname: Huggins – volume: 60 start-page: 135 year: 2009 end-page: 148 ident: bib15 article-title: MAP kinase and pain publication-title: Brain Res Rev contributor: fullname: Strichartz – volume: 24 start-page: 8310 year: 2004 end-page: 8321 ident: bib20 article-title: Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization publication-title: J Neurosci contributor: fullname: Ji – volume: 148 start-page: 102 year: 2006 end-page: 113 ident: bib6 article-title: Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms publication-title: Br J Pharmacol contributor: fullname: Webb – volume: 33 start-page: 1851 year: 2012 end-page: 1862 ident: bib23 article-title: Cationic glycopolymers for the delivery of pDNA to human dermal fibroblasts and rat mesenchymal stem cells publication-title: Biomaterials contributor: fullname: Reineke – volume: 24 start-page: 907 year: 2012 end-page: 913 ident: bib27 article-title: MKP-1: A negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells publication-title: Cell Signal contributor: fullname: Ammit – volume: 8 start-page: 34 year: 2012 ident: bib28 article-title: Mitogen activated protein kinase phosphatase-1 prevents the development of tactile sensitivity in a rodent model of neuropathic pain publication-title: Mol Pain contributor: fullname: Romero-Sandoval – volume: 6 start-page: 16 year: 2010 ident: bib36 article-title: Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain publication-title: Mol Pain contributor: fullname: Frey – volume: 53 start-page: 55 year: 1994 end-page: 63 ident: bib7 article-title: Quantitative assessment of tactile allodynia in the rat paw publication-title: J Neurosci Methods contributor: fullname: Yaksh – volume: 37 start-page: 511 year: 2009 end-page: 519 ident: bib13 article-title: Recombinant human erythropoietin protects against experimental spinal cord trauma injury by regulating expression of the proteins MKP-1 and p-ERK publication-title: J Int Med Res contributor: fullname: Zhang – volume: 6 start-page: 391 year: 2007 end-page: 403 ident: bib14 article-title: Targeting dual-specificity phosphatases: Manipulating MAP kinase signalling and immune responses publication-title: Nat Rev Drug Discov contributor: fullname: Mackay – ident: 10.1016/j.jpain.2012.05.013_bib2 – volume: 108 start-page: 722 year: 2008 ident: 10.1016/j.jpain.2012.05.013_bib30 article-title: Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury publication-title: Anesthesiology doi: 10.1097/ALN.0b013e318167af74 contributor: fullname: Romero-Sandoval – volume: 6 start-page: 16 year: 2010 ident: 10.1016/j.jpain.2012.05.013_bib36 article-title: Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain publication-title: Mol Pain doi: 10.1186/1744-8069-6-16 contributor: fullname: Toth – volume: 37 start-page: 511 year: 2009 ident: 10.1016/j.jpain.2012.05.013_bib13 article-title: Recombinant human erythropoietin protects against experimental spinal cord trauma injury by regulating expression of the proteins MKP-1 and p-ERK publication-title: J Int Med Res doi: 10.1177/147323000903700227 contributor: fullname: Huang – volume: 49 start-page: 67 year: 2006 ident: 10.1016/j.jpain.2012.05.013_bib8 article-title: The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells publication-title: Neuron doi: 10.1016/j.neuron.2005.11.027 contributor: fullname: Eljaschewitsch – volume: 106 start-page: 2056 year: 2008 ident: 10.1016/j.jpain.2012.05.013_bib10 article-title: Cisplatin-mediated activation of extracellular signal-regulated kinases 1/2 (ERK1/2) by inhibition of ERK1/2 phosphatases publication-title: J Neurochem doi: 10.1111/j.1471-4159.2008.05550.x contributor: fullname: Gozdz – volume: 53 start-page: 55 year: 1994 ident: 10.1016/j.jpain.2012.05.013_bib7 article-title: Quantitative assessment of tactile allodynia in the rat paw publication-title: J Neurosci Methods doi: 10.1016/0165-0270(94)90144-9 contributor: fullname: Chaplan – volume: 24 start-page: 8310 year: 2004 ident: 10.1016/j.jpain.2012.05.013_bib20 article-title: Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2396-04.2004 contributor: fullname: Kawasaki – volume: 382 start-page: 663 year: 2009 ident: 10.1016/j.jpain.2012.05.013_bib29 article-title: Possible involvement of mitogen-activated protein kinase phosphatase-1 (MKP-1) in thyrotropin-releasing hormone (TRH)-induced prolactin gene expression publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.03.061 contributor: fullname: Oride – volume: 5 start-page: 382 year: 2011 ident: 10.1016/j.jpain.2012.05.013_bib5 article-title: Addition of intrathecal Dexamethasone to Bupivacaine for spinal anesthesia in orthopedic surgery publication-title: Saudi J Anaesth doi: 10.4103/1658-354X.87267 contributor: fullname: Bani-Hashem – volume: 23 start-page: 4017 year: 2003 ident: 10.1016/j.jpain.2012.05.013_bib16 article-title: p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain publication-title: J Neurosci doi: 10.1523/JNEUROSCI.23-10-04017.2003 contributor: fullname: Jin – volume: 5 start-page: e10891 year: 2010 ident: 10.1016/j.jpain.2012.05.013_bib3 article-title: Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain publication-title: PLoS One doi: 10.1371/journal.pone.0010891 contributor: fullname: Alkaitis – volume: 27 start-page: 851 year: 2011 ident: 10.1016/j.jpain.2012.05.013_bib11 article-title: Blood levels of dual-specificity phosphatase-1 independently predict risk for post-operative morbidities causing prolonged hospitalization after coronary artery bypass grafting publication-title: Int J Mol Med contributor: fullname: Hagg – volume: 41 start-page: 376 year: 2012 ident: 10.1016/j.jpain.2012.05.013_bib24 article-title: Effect of single dose preoperative intramuscular dexamethasone injection on lower impacted third molar surgery publication-title: Int J Oral Maxillofac Surg doi: 10.1016/j.ijom.2011.12.014 contributor: fullname: Klongnoi – volume: 15 start-page: 1040 year: 2011 ident: 10.1016/j.jpain.2012.05.013_bib4 article-title: Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury publication-title: Eur J Pain doi: 10.1016/j.ejpain.2011.04.005 contributor: fullname: Anand – volume: 14 start-page: 331 year: 2008 ident: 10.1016/j.jpain.2012.05.013_bib21 article-title: Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain publication-title: Nat Med doi: 10.1038/nm1723 contributor: fullname: Kawasaki – volume: 33 start-page: 1851 year: 2012 ident: 10.1016/j.jpain.2012.05.013_bib23 article-title: Cationic glycopolymers for the delivery of pDNA to human dermal fibroblasts and rat mesenchymal stem cells publication-title: Biomaterials doi: 10.1016/j.biomaterials.2011.10.031 contributor: fullname: Kizjakina – volume: 108 start-page: 316 year: 2009 ident: 10.1016/j.jpain.2012.05.013_bib18 article-title: Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase publication-title: Anesth Analg doi: 10.1213/ane.0b013e31818c7cbd contributor: fullname: Karbarz – volume: 5 start-page: e13754 year: 2010 ident: 10.1016/j.jpain.2012.05.013_bib33 article-title: Transcriptional regulation of human dual specificity protein phosphatase 1 (DUSP1) gene by glucocorticoids publication-title: PLoS One doi: 10.1371/journal.pone.0013754 contributor: fullname: Shipp – volume: 102 start-page: 667 year: 2007 ident: 10.1016/j.jpain.2012.05.013_bib39 article-title: Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia publication-title: J Neurochem doi: 10.1111/j.1471-4159.2007.04535.x contributor: fullname: Zhou – volume: 24 start-page: 907 year: 2012 ident: 10.1016/j.jpain.2012.05.013_bib27 article-title: MKP-1: A negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells publication-title: Cell Signal doi: 10.1016/j.cellsig.2011.12.013 contributor: fullname: Manetsch – volume: 8 start-page: 34 year: 2012 ident: 10.1016/j.jpain.2012.05.013_bib28 article-title: Mitogen activated protein kinase phosphatase-1 prevents the development of tactile sensitivity in a rodent model of neuropathic pain publication-title: Mol Pain doi: 10.1186/1744-8069-8-34 contributor: fullname: Ndong – volume: 148 start-page: 102 year: 2006 ident: 10.1016/j.jpain.2012.05.013_bib6 article-title: Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0706699 contributor: fullname: Chang – volume: 107 start-page: 779 year: 2008 ident: 10.1016/j.jpain.2012.05.013_bib9 article-title: Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and JNK in LPS-treated microglia publication-title: J Neurochem doi: 10.1111/j.1471-4159.2008.05653.x contributor: fullname: Gong – volume: 5 start-page: 513 year: 2003 ident: 10.1016/j.jpain.2012.05.013_bib19 article-title: MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb publication-title: Nat Cell Biol doi: 10.1038/ncb989 contributor: fullname: Kawakami – volume: 203 start-page: 1883 year: 2006 ident: 10.1016/j.jpain.2012.05.013_bib1 article-title: Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 publication-title: J Exp Med doi: 10.1084/jem.20060336 contributor: fullname: Abraham – volume: 73 start-page: 706 year: 2012 ident: 10.1016/j.jpain.2012.05.013_bib26 article-title: Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2011.04137.x contributor: fullname: Li – volume: 110 start-page: 155 year: 2009 ident: 10.1016/j.jpain.2012.05.013_bib37 article-title: Activation of p38 mitogen-activated protein kinase in spinal microglia contributes to incision-induced mechanical allodynia publication-title: Anesthesiology doi: 10.1097/ALN.0b013e318190bc16 contributor: fullname: Wen – volume: 6 start-page: 391 year: 2007 ident: 10.1016/j.jpain.2012.05.013_bib14 article-title: Targeting dual-specificity phosphatases: Manipulating MAP kinase signalling and immune responses publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2289 contributor: fullname: Jeffrey – volume: 322 start-page: 236 year: 2007 ident: 10.1016/j.jpain.2012.05.013_bib32 article-title: The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.107.119941 contributor: fullname: Russo – volume: 48 start-page: 2059 year: 2011 ident: 10.1016/j.jpain.2012.05.013_bib25 article-title: Attenuation of the acute inflammatory response by dual specificity phosphatase 1 by inhibition of p38 MAP kinase publication-title: Mol Immunol doi: 10.1016/j.molimm.2011.06.439 contributor: fullname: Korhonen – volume: 52 start-page: 717 year: 2012 ident: 10.1016/j.jpain.2012.05.013_bib35 article-title: Novel p38alpha Mitogen-activated protein kinase inhibitor shows analgesic efficacy in acute postsurgical dental pain publication-title: J Clin Pharmacol doi: 10.1177/0091270011405496 contributor: fullname: Tong – volume: 126 start-page: 618 year: 2010 ident: 10.1016/j.jpain.2012.05.013_bib17 article-title: Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2010.06.007 contributor: fullname: Jin – volume: 5 start-page: 25 year: 2009 ident: 10.1016/j.jpain.2012.05.013_bib31 article-title: Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation publication-title: Mol Pain doi: 10.1186/1744-8069-5-25 contributor: fullname: Romero-Sandoval – volume: 60 start-page: 135 year: 2009 ident: 10.1016/j.jpain.2012.05.013_bib15 article-title: MAP kinase and pain publication-title: Brain Res Rev doi: 10.1016/j.brainresrev.2008.12.011 contributor: fullname: Ji – volume: 42 start-page: 15197 year: 2003 ident: 10.1016/j.jpain.2012.05.013_bib22 article-title: Intramolecular dephosphorylation of ERK by MKP3 publication-title: Biochemistry doi: 10.1021/bi035346b contributor: fullname: Kim – volume: 186 start-page: 5863 year: 2011 ident: 10.1016/j.jpain.2012.05.013_bib34 article-title: CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection publication-title: J Immunol doi: 10.4049/jimmunol.1003957 contributor: fullname: Srivastava – volume: 8 start-page: 235 year: 2002 ident: 10.1016/j.jpain.2012.05.013_bib12 article-title: Efficient transfection method for primary cells publication-title: Tissue Eng doi: 10.1089/107632702753725003 contributor: fullname: Hamm – volume: 280 start-page: 8101 year: 2005 ident: 10.1016/j.jpain.2012.05.013_bib38 article-title: The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: Attenuation of proinflammatory cytokine biosynthesis via feedback control of p38 publication-title: J Biol Chem doi: 10.1074/jbc.M411760200 contributor: fullname: Zhao |
SSID | ssj0011577 |
Score | 2.277877 |
Snippet | Abstract Peripheral nerve injury generally results in spinal neuronal and glial plastic changes associated with chronic behavioral hypersensitivity. Spinal... Peripheral nerve injury generally results in spinal neuronal and glial plastic changes associated with chronic behavioral hypersensitivity. Spinal... |
SourceID | pubmedcentral crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 836 |
SubjectTerms | 4-Nitrophenylphosphatase - metabolism Anesthesia & Perioperative Care Animals CB2 receptors Disease Models, Animal Diterpenes - therapeutic use Dual Specificity Phosphatase 1 - metabolism Dual Specificity Phosphatase 6 - metabolism Epoxy Compounds - therapeutic use Gene Expression Regulation - drug effects Hyperalgesia - drug therapy Hyperalgesia - etiology Hyperalgesia - pathology Immunosuppressive Agents - therapeutic use Indoles - pharmacology Indoles - therapeutic use Male MAPK phosphatase mitogen-activated protein kinase (MAPK) Mitogen-Activated Protein Kinase Phosphatases - classification Mitogen-Activated Protein Kinase Phosphatases - metabolism Nerve Tissue Proteins - metabolism Neuralgia - complications pain Pain Medicine Phenanthrenes - therapeutic use Rats Rats, Sprague-Dawley Receptor, Cannabinoid, CB2 - agonists Receptor, Cannabinoid, CB2 - antagonists & inhibitors Signal Transduction - drug effects spinal cord Spinal Cord - drug effects Spinal Cord - metabolism Time Factors |
Title | Spinal Cannabinoid Receptor Type 2 Agonist Reduces Mechanical Allodynia and Induces Mitogen-Activated Protein Kinase Phosphatases in a Rat Model of Neuropathic Pain |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S1526590012006657 https://dx.doi.org/10.1016/j.jpain.2012.05.013 https://www.ncbi.nlm.nih.gov/pubmed/22901764 https://pubmed.ncbi.nlm.nih.gov/PMC3438333 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9wwDDbLHkovpe9OX-jQY9NJYjvOHoehy9IyZeh2YW_G8aOTZUjCJj300l_TH1rJSYYOhRZ6SxwFC0uWJSx9YuyNdJYKFi1BX7pEVEElxokyMdzkubOW-3iju_lUXFyJD9fy-oSt51oYSqucbP9o06O1nkaW02ouu7peXmaE7H4Wqz_j_QFVsONhhDr97schzYOwZGKDFSROiHpGHoo5Xjcdht-U35WP8J38n6fTcebkb0fR-X12b_IhYTWy-YCd-OYhu7OZbskfsZ-XHfW6grVpGoORb1s7QPfQdxhfAwWekMPqa0uYuTjuULg9bDyVAJPEYLXft-57UxswjQPq7REJcOujsiUrGxuieQdbgnioG_iIk_Uetru273ZmwOcecNjAZzMA9VrbQxsgooDE_scWtrgej9nV-fsv64tk6saQWFmmQyKULYNTqiozaYTgZSiDKTDgkhU6WcKcWS9ccLkz6PWEHN1IdJ24LYKSMnBV8SfstGkb_4xBlcoyU7ywUqVCGGl8JdAvU2kl8twqs2BvZynobgTd0HM22o2OQtMkNJ1KjUJbMDVLSs_1pGgBfT9tx15nukdi_YfKLFhx-PNI6zQeKH-f8umoCAf-CDc_U4VAZo5U5EBAON7HX5p6F_G8OcHFcv78f5l5we7S25j59pKdDrff_Ct0lYbqddwLvwAkyBO5 |
link.rule.ids | 230,315,786,790,891,4521,27957,27958,45620 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkYAL4s3ynANHwm5iO06PqxXVQrvVirZSb5ZjO91UqyQi4cCFX8MPZcZJVqyQQOIW2RPZ8oztb-SZbxh7J52lhEVL1JcuEnmhIuNEFhluksRZy3140V2dpctL8flKXh2wxZgLQ2GVw9nfn-nhtB5apsNqTpuynJ7HxOx-FLI_w_vBLXab4DzVb_jwYxfnQWQyocIKSkckPlIPhSCvmwb9bwrwSnr-Tv7P62k_dPK3u-j4Abs_gEiY9_N8yA589YjdWQ3P5I_Zz_OGil3BwlSVQde3Lh0gPvQNOthAnickML-uiTQX2x1qt4WVpxxgUhnMt9vafa9KA6ZyQMU9ggDufbS2aG5DRTTvYE0cD2UFJzhY62G9qdtmYzr8bgGbDXwxHVCxtS3UBQQakFAA2cIa1-MJuzz-eLFYRkM5hsjKbNZFQtmscErlWSyNEDwrssKk6HHJHFGWMEfWC1e4xBmEPUWCOBKxE7dpoaQsuMr5U3ZY1ZV_ziCfySxWPLVSzYQw0vhcIDBTs1wkiVVmwt6PWtBNz7qhx3C0Gx2UpklpeiY1Km3C1KgpPSaU4hHo22E_tjrWLQrrP2xmwtLdn3tmp_FG-fuQz3pD2M2PiPNjlQqczJ6J7ASIyHu_pyo3gdCbE18s5y_-dzJv2d3lxepUn346O3nJ7lFPHwb3ih12X7_514ibuvxN2Be_AP87Ftk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Spinal+cannabinoid+receptor+type+2+agonist+reduces+mechanical+allodynia+and+induces+mitogen-activated+protein+kinase+phosphatases+in+a+rat+model+of+neuropathic+pain&rft.jtitle=The+journal+of+pain&rft.au=Landry%2C+Russell+P.&rft.au=Martinez%2C+Elena&rft.au=DeLeo%2C+Joyce+A.&rft.au=Romero-Sandoval%2C+E.+Alfonso&rft.date=2012-09-01&rft.issn=1526-5900&rft.eissn=1528-8447&rft.volume=13&rft.issue=9&rft.spage=836&rft.epage=848&rft_id=info:doi/10.1016%2Fj.jpain.2012.05.013&rft_id=info%3Apmid%2F22901764&rft.externalDBID=PMC3438333 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15265900%2FS1526590012X00099%2Fcov150h.gif |